|
| | |
|
Press Release
DCAT Welcomes Seven New Member Companies
Robbinsville, NJ, February 7, 2011 – – The Drug, Chemical and Associated Technology Association (DCAT), the pharmachem industry’s premier business development association, is pleased to announce the following new member companies: Contract Pharmaceuticals Limited (CPL), Ecadil S/A, Impopharma Inc., Norwich Pharmaceuticals, Semler Research Center Pvt, Ltd., Sri Krishna Pharmaceuticals Ltd., Xerimis, Inc. To learn about other DCAT member companies, visit DCAT’s Meet Our Members.
Contract Pharmaceuticals Limited (CPL)
CPL is a leading contract manufacturer specializing in the development, manufacturing, packaging and testing of liquid and semisolid preparations. With an outstanding record of regulatory compliance and a focus on lean manufacturing, CPL's GMP operations provide superior support in formulation development, clinical trial requirements and commercial production. www.cplltd.com
Ecadil S/A
With its three profitable business areas Ecadil is active in attractive markets. We are a South American leader in specialty chemicals, an expert in API´s and its intermediates, and one of the largest private chemical companies in Brazil. Today Ecadil is launching a generic dosages plant. With more than 50 % of the Brazilian API´s local market and partnerships with the most important pharmaceuticals, cosmetics and biotech companies Ecadil has key drivers to ensure profitable growth in the future. www.ecadil.com.br
Impopharma Inc.
Impopharma Inc. is a Research & Development Pharmaceutical Company with a state of the art facility specializing in Development Services for nasal and pulmonary delivery. This includes Formulation Development, Analytical Development, Production Process Development, Device Development, Manufacturing of Stability/Clinical batches, Regulatory support, Technology transfer, On Site (Clients or Impopharma's Facility) Training. Impopharma acts as an extension of the clients laboratory with access to highly specialized equipment, key scientists as well as expertise in many R&D disciplines, including up to date research strategy. www.impopharma.com
Norwich Pharmaceuticals
Norwich Pharmaceuticals is a full-service contract development and manufacturing provider for Rx and OTC products. From clinical development through scale-up to commercial launch, we apply more than 120 years of experience and an unparalleled compliance record to the production, packaging and distribution of solid dose, semi-solid, liquid formulation and transdermal patch technology. Norwich continues to invest in technology and talent to maintain a solid reputation for flexibility and responsiveness to customer needs. Our uncommon value is generated by producing quality products that meet or exceed customer and regulatory expectations with everyday excellence. www.norwichpharma.com
Semler Research Center Pvt, Ltd.
Semler Research Center (SRC) is a CRO with top management and scientific staff, state-of-the-art R&D centers in Bangalore and Salem in India, with corporate business development and project management offices in Los Angeles. SRC offers a wide range of services which include BA/BE, pK, clinical /formulation development and GMP consulting. www.semlerresearch.com
Sri Krishna Pharmaceuticals Ltd.
Sri Krishna Pharma (SKPL), with exports to over 75 countries, is a focused, "Generic-Centric" company offering innovative solutions across the value-chain. SKPL, is one of the largest producers of folic-acid and acetaminophen in India. From its state of art formulation facility, SKPL offers direct compression grades and microencapsulated products of APAP (Paracetamol), Ibuprofen, Metformin, Guaifenesin, Aspirin, other API's and combinations thereof. SKPL facilities have been GMP approved by USFDA, TGA & E.U. Health Authorities (French/Italian). www.srikrishnapharma.com
Xerimis, Inc.
Xerimis works with large and small pharmaceutical and biotech companies who are trying to get a new compound to market. We prepare the patient kits and ship them to clinical sites as patients are recruited into the clinical study. www.Xerimis.com
About DCAT
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical, and related industries.
Contact:
Erin Sanders
DCAT Communications Coordinator
609-448-1000 |
| |
| | |
|